ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo
Clinical trial NCT05070260 · COMPLETED
Trial details
- NCT number
- NCT05070260
- Sponsor
- Acticor Biotech
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-23
- Primary completion
- 2024-04-30
- Enrollment
- 438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.